Rapid Micro Biosystems (RPID) Net Cash Flow (2020 - 2026)

Rapid Micro Biosystems has disclosed Net Cash Flow across 7 years of filings, most recently posting -$6.2 million for Q1 2026.

• Net Cash Flow for Q1 2026 came in at -$6.2 million, down 411.53% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.2 million (down 50.09% YoY), and the FY2025 annual result was $3.0 million, up 141.66% from the prior year.
• Net Cash Flow came in at -$6.2 million for Q1 2026 at Rapid Micro Biosystems, down from $1.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $14.7 million in Q2 2024 to a low of -$115.9 million in Q1 2022.
• The 5-year median for Net Cash Flow is -$1.9 million (2024), against an average of -$9.7 million.
• Peak annual rise in Net Cash Flow reached 243.98% in 2024, while the deepest fall reached 1112.42% in 2024.
• Rapid Micro Biosystems' Net Cash Flow stood at $1.2 million in 2022, then sank by 59.5% to $499000.0 in 2023, then slumped by 1112.42% to -$5.1 million in 2024, then surged by 121.46% to $1.1 million in 2025, then sank by 673.34% to -$6.2 million in 2026.
• The last three Net Cash Flow figures came in at -$6.2 million (Q1 2026), $1.1 million (Q4 2025), and $613000.0 (Q3 2025), per Business Quant data.